These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. Uncovering the ferroptosis related mechanism of laduviglusib in the cell-type-specific targets of the striatum in Huntington's disease. Liu M; Zhao J; Xue C; Yang J; Ying L BMC Genomics; 2024 Jun; 25(1):633. PubMed ID: 38918688 [TBL] [Abstract][Full Text] [Related]
11. The paradigm of Huntington's disease: therapeutic opportunities in neurodegeneration. Leegwater-Kim J; Cha JH NeuroRx; 2004 Jan; 1(1):128-38. PubMed ID: 15717013 [TBL] [Abstract][Full Text] [Related]
12. Cell Replacement Therapy for Huntington's Disease. Monk R; Connor B Adv Exp Med Biol; 2020; 1266():57-69. PubMed ID: 33105495 [TBL] [Abstract][Full Text] [Related]
14. Dysregulation of synaptic proteins, dendritic spine abnormalities and pathological plasticity of synapses as experience-dependent mediators of cognitive and psychiatric symptoms in Huntington's disease. Nithianantharajah J; Hannan AJ Neuroscience; 2013 Oct; 251():66-74. PubMed ID: 22633949 [TBL] [Abstract][Full Text] [Related]
15. Transplanted fetal striatum in Huntington's disease: phenotypic development and lack of pathology. Freeman TB; Cicchetti F; Hauser RA; Deacon TW; Li XJ; Hersch SM; Nauert GM; Sanberg PR; Kordower JH; Saporta S; Isacson O Proc Natl Acad Sci U S A; 2000 Dec; 97(25):13877-82. PubMed ID: 11106399 [TBL] [Abstract][Full Text] [Related]
16. Huntington's disease and cell therapies: past, present, and future. Antoniades CA; Watts C Methods Mol Biol; 2013; 1010():19-32. PubMed ID: 23754216 [TBL] [Abstract][Full Text] [Related]
17. Animal models of Huntington's disease: implications in uncovering pathogenic mechanisms and developing therapies. Wang LH; Qin ZH Acta Pharmacol Sin; 2006 Oct; 27(10):1287-302. PubMed ID: 17007735 [TBL] [Abstract][Full Text] [Related]
18. Huntington's disease: From molecular basis to therapeutic advances. Krobitsch S; Kazantsev AG Int J Biochem Cell Biol; 2011 Jan; 43(1):20-4. PubMed ID: 21056115 [TBL] [Abstract][Full Text] [Related]
19. Immunomodulatory Strategies for Huntington's Disease Treatment. Colpo GD; Rocha NP; Stimming EF; Teixeira AL CNS Neurol Disord Drug Targets; 2017; 16(8):936-944. PubMed ID: 28606048 [TBL] [Abstract][Full Text] [Related]
20. Stem cell therapy and cellular engineering for treatment of neuronal dysfunction in Huntington's disease. Choi KA; Hwang I; Park HS; Oh SI; Kang S; Hong S Biotechnol J; 2014 Jul; 9(7):882-94. PubMed ID: 24827816 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]